• 2831 results found
  • There are 0 active filters
Filter by
Filters
Filter results

Date

Primary topics

All topics

Types of content

All types

Products

All products

Diseases

All diseases

General Terms

All terms

Geography

All locations

Campaigns

All campaigns

Institutions & Events

All events and institutions

Report series

All publications

Miscellaneous

All miscellaneous
Apply
Clear all filters
2831 results found
MSF collaborated with local NGOs to support vulnerable groups during the COVID Omicron wave, Hong Kong, March 2022.
Blog |
13 March 2023

Amid scarcity and soaring prices, China could issue compulsory license for Paxlovid

After three years of its “Zero COVID” policy, the Chinese government allowed a return to relative normalcy for its citizens in early December 2022. Due to the ongoing transmission of Omicron and its numerous COVID subvariants in China, the sudden policy shift was accompanied by rapid community transmission across the country and high numbers of severe COVID cases.

Jepngok Kiptui was just three when she was bitten by a snake while sleeping in her bed at home in Baringo County, North-Western Kenya. It took more than five hours to get her to the county’s main referral hospital, after being referred from two hospitals that lacked the capacity to treat her. Little Cheptui had to undergo three surgeries: the first to remove the dead tissues killed by the snake’s venom, and two skin grafting surgeries. Photograph by Paul Odongo
Blog |
09 February 2023

Snakebite reflecting on the neglected disease

Some diseases are more neglected than others. This is the case with snakebites, which are responsible for more than 100,000 deaths every year worldwide. A recent MSF publication in Toxicon X highlights the resources needed to improve the management of snakebite venom poisoning in resource-limited settings.

Dilaram, a former TB-PRACTECAL clinical trial patient, in Nukus, Karakalpakstan, Uzbekistan. Photograph by Victoria Gendina
Blog |
17 January 2023

New, shorter treatment brings hope for TB patient Dilaram

In late 2022, science delivered when we shared the stunning results of a five-year clinical trial for a groundbreaking new treatment regimen for people living with drug-resistant TB. Ahead in 2023, we are looking forward to seeing the benefits to people’s lives as the treatment is rolled out in MSF projects and beyond. Here is the story of Dilaram, a nurse from Uzbekistan, about her participation in the clinical trial and how it changed her life.